Current topics in glaucoma

Journal of Japanese Ophthalmological Society

Volumn 100, Issue 12, 1996, Pages 923-936

  Masuda, Kanjiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Ca ++ blockers; Glaucoma; Laser speckle phenomenon; Latanoprost; Mitomycin C; Nipradilol; Normal tension glaucoma; Ocular blood flow

Indexed keywords

FLUOROURACIL; LATANOPROST; MITOMYCIN C; NILVADIPINE; NIPRADILOL; TIMOLOL;

CONFERENCE PAPER; DRUG EFFECT; EYE BLOOD FLOW; FILTERING OPERATION; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; TRABECULOPLASTY; TREATMENT OUTCOME; VISION; VISUAL FIELD;

ADULT; ANIMALS; FEMALE; GLAUCOMA; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MITOMYCIN; PROPANOLAMINES; PROSTAGLANDINS F, SYNTHETIC;

EID: 0030471015     PISSN: 00290203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (65)

1. Shiose Y, Kitazawa Y, Tsukahara S, Akamatsu T, Mizokami K, Futa R, et al: Epidemiology of glaucoma in Japan. A nationwide glaucoma survey. Jpn J Ophthalmol 35: 13-155, 1991.
2. Roth SM, Spaeth GL, Starita RJ, Birbillis EM, Steinmann WC: The effects of postoperative corticosteroids on trabeculectomy and the clinical course of glaucoma: Five-year follow-up study. Ophthalmic Surg 22: 724-729, 1991.
3. Kidd MN, O'connor M: Progression of field loss after trabeculectomy ; A five-year follow-up. Br J Ophthalmol 69: 827-831, 1985.
4. Kolker AE: Visual prognosis in advanced glaucoma: A comparison of medical and surgical therapy for retention of vision in 101 eyes with advanced glaucoma. Trans Am Ophthalmol Soc 75: 539-555, 1977.
5. Werner EB, Drance SM, Schulzer M: Trabeculectomy and the progression of glaucomatous visual field loss. Arch Ophthalmol 95: 1374-1377, 1977.
6. Stewart WC, Chorak RP, Hunt HH, Sethuraman G: Factors associated with visual loss in patients with advanced glaucomatous changes in the optic nerve head. Am J Ophthalmol 116: 176-181, 1993.
7. O'Brien C, Schwartz B, Takamoto T, Wu DC: Intraocular pressure and the rate of visual field loss in chronic open-angle glaucoma. Am J Ophthalmol 111: 491-500, 1991.
8. Popovic V, Sjostrand J: Long-term outcome following trabeculectomy I. Acta Ophthalmol 69: 299-304, 1991.
9. Greve EL, Dake CL: Four-year follow-up of glaucoma operation. Prospective study of the double flap Scheie. Int Ophthalmol 1: 139-145, 1979.
10. Holmin C, Poulsen AS: The visual field after trabeculectomy. Acta Ophthalmol 62: 230-234, 1984.
11. Chauhan BC, Drance SM: The relationship between intraocular pressure and visual field progression in glaucoma. Graefes Arch Clin Exp Ophthalmol 230: 521-526, 1992.
12. Jay JL, Murray SB: Early trabeculectomy versus conventional management in primary open angle glaucoma. Br J Ophthalmol 72: 881-889, 1988.
13. Rollin DF, Drance SM: Five-year follow-up of trabeculactomy in the management of chronic open-angle glaucoma. New Orleans Acad Ophthalmol, Symposium on glaucoma ; 295-300, 1981.
14. Mikelberg FS, Drance SM: The mode of progression of visual field defects in glaucoma. Am J Ophthalmol 98: 443-445, 1984.
15. Mao LK, Stewart WC, Shields MB: Correlation between intraocular pressure control and progressive glaucomatous damage in primary open-angle glaucoma. Am J Ophthalmol 111: 51-55, 1991.
16. Odberg T: Visual field prognosis in early glaucoma. A long-term clinical follow-up. Acta Ophthalmol 71: 721-726, 1993.
17. Hart WM, Becker B: The onset and evolution of glaucomatous visual field defects. Am Acad Ophthalmol 89: 268-279, 1982.
18. Stjernschantz J, Resul J: Phenyl substituted prostaglandin analogs for glaucoma treatment. Drug Future 17: 691-704, 1992.
19. 2α analogue, after topical application in normal and ocular hypertensive human eyes. Arch Ophthalmol 111: 1351-1358, 1993.
20. 2α analog on aqueous human dynamics in human eyes. Ophthalmology 100: 1297-1304, 1993.
21. Frechtner RD, Weinreb RN: Mechanisms of optic nerve damage in primary open angle glaucoma. Surv Ophthalmol 39: 23-42, 1994.
22. Tamaki Y, Araie M, Kawamoto E, Eguchi S, Fnjii H: Noncontact. two-dimensional measurement of retinal microcirculation using laser speckle phenomenon. Invest Ophthalmol Vis Sci 35: 3825-3834, 1994.
23. Tamaki Y, Araie M, Kawamoto E, Eguchi S, Fujii S: Non-contact, two-dimensional measurement of tissue circulation in choroid and optic never head using laser speckle phenomenon. Exp Eye Res 60: 373-384, 1995.
24. Uchida Y, Nakamura M, Shimizu S, Shirasawa Y, Fujii M: Vasoactive and β-adrenoceptor blocking properties of 3,4-dihydro-8-(2-hydroxy-3 isopropylamino) propoxy-3 nitroxy-2H-1-benzopyran (K-351), a New Antihypertensive Agent. Archives Internationales de Pharmacodynamie et de Therapie 262: 132-149, 1983.
25. Hayashi M, Yablonski ME, Novack GD: Trabecular outflow facility determined by fluorophotometry in human subjects. Exp Eye Res 48: 621-625, 1989.
26. Suguro K, Toris C, Pederson JE: Uveoscleral outflow following cyclodialysis in the monkey eye using a fluorescent tracer. Invest Ophthalmol Vis Sci 26: 810-813, 1985.
27. Inaba Z: Long-term results of trabeculectomy in the Japanese: An analysis by life table method. Jpn J Ophthalmol 26: 361-373, 1982.
28. Yamashita H, Eguchi S, Yamamoto T, Shirato S: Trabeculectomy. A prospective study of complication and results of long-term follow up. Jpn J Ophthalmol 29: 250-262, 1985.
29. Yamamoto T, Varani J, Soong HK, Lichter PR: Effect of 5-fluorouracil and mitomycin C on cultured rabbit subconjunctivel fibroblasts. Ophthalmology 97: 1204 -1210, 1990.
30. Kitazawa Y, Suemori MI, Yamamoto T, Kawase K: Low-dose and high-dose mitomycin trabeculectomy as an initial surgery in primary open-angle glaucoma. Ophthalmology 100: 1624-1628, 1993.
31. Xeelankantan A, Rao BS, Vijara L, Grandham SB, Krinshman N, Priya S, et al: Effect of the concentration and duration of application of mitomycin C in trabeculectomy. Ophthalmic Surg 25: 612-615, 1994.
32. Mizura GE, Karakuck S, Dogan H, Erkilic K: Filtration surgery with mitomycin C in uncomplicated glaucoma. Acta Ophthalmol 72: 155-161, 1994.
33. Cox DR: Regression models and life tables. J R Stat Soc 34: 248-275, 1972 (SAS/STAT User's Guide, Releaaase 6.30 ed. NC : SAS Institute, 1998).
34. Yamagami J, Araie M, Shirato S: A comparative study of optic nerve head in low- and high-tension glaucoma. Graefes Arch Clin Exp Ophthalmol 230: 446-450, 1992.
35. Weinreb RN, Shakiba S, Zangwill L: Scaning laser polarimetry to measure the nerve fiber layer of normal and glaucomatous eyes. Am J Ophthalmol 119: 627-636, 1995.
36. Araie M, Yamagami J, Suzuki Y: Visual field defects in normal-tension and high-tension glaucoma. Ophthalmology 100: 1808-1814, 1993.
37. Koseki N, Araie M, Suzuki Y, Yamagami J: Visual field damage proximal to fixation in normal- and high-tension glaucoma eyes. Jpn J Ophthalmol 39: 274-283, 1995.
38. Araie M, Sekine M, Suzuki Y, Koseki N: Factors contributing to the progression of visual field damage in eyes with normal-tension glaucoma. Ophthalmology 101: 1440-1444, 1994.
39. Shields MB: Primary open-angle glaucoma, In: Textbook of Glaucoma, Williams & Wilkins, 172 -197, 1992.
40. Abedin S, Simmons RS, Grant MW: Progressive low-tension glaucoma treatment to stop glaucomatous cupping and field loss when these progress despite normal intraocular pressure. Ophthalmology 89: 1-6, 1982.
41. de Jong N, Greve EL, Hoyng PFJ, Geijssen HC: Results of a filtering procedure in low tension glaucoma. Int Ophthalmol 13: 131-138, 1989.
42. Hitchings RA, Wu J, Poinoosawmy D, McNaught A: Surgery for normal tension glaucoma. Br J Ophthalmol 79: 402-406, 1995.
43. 2+-antagonist on visual field in low-tension glaucoma. Graefes Arch Clin Exp Ophthalmol 227: 12-408, 1989.
44. Netland PA, Chaturvedi N, Dreyer EB: Calcium channel blockers in the management of low-tension and open-angle glaucoma. Am J Ophthalmol 115: 13-608, 1993.
45. Sawada S, Kitazawa Y, Yamamoto T, Okabe I, Ichien K: Prevention of visual field defect progression with brovincamine in eyes with normal-tension glaucoma. Ophthalmology 103: 283-288, 1996.
46. Kushiku K, Katsuragi T, Mori R, Morishita H, Furukawa T, et al: Cardiovascular effects of brovincamine and possible mechanisms involved. Clin Exp Pharmacol Physiol 12: 121-130, 1985.
47. Tamaki Y, Araie M, Tomita K, Nagahara M, Tomidokoro A, Fujii H: Real-time measurement of tissue circulation in optic never head or choroid in human eyes using laser speckle phenomenon. Jpn J Ophthalmol 1997 (in press).
48. Tamaki Y, Araie M, Tomita K, Tomidokoro A: Time change of nicardipine effect on tissue circulation in retina and optic nerve head in living rabbit eyes. Jpn J Ophthalmol 1996 (in press).
49. Mcsorley PD, Warren DJ: Effects of propranolol and metoprolol on peripheral circulation. Br Med J 2: 1598-1600, 1978.
50. Hester RK, Chen Z, Becker EJ, McIauchlin M, Desantis L: The direct vascular relaxing action of betaxolol, carteolol and timolol in porcine long posterior ciliary artery. Surv Ophthalmol 38(Supple): 125-134, 1994.
51. Novack GD: Ophthalmic beta-blockers since timolol. Surv Ophthalmol 31: 307-327, 1987.
52. Janczewski P, Boulanger C, Iqbal A, Vanhoutte PM: Endothelium-dependent effects of carteolol. J Pharmacol Exp Therap 247: 590-595, 1987.
53. Beresford. R, Heel RC: Betaxiol. A review of its parmacodynamic and pharmacokinetic poperties. and terapeutic efficacy in hypertension. Drugs 31: 6-28, 1986.
54. Acheampong AA, Breau A, Shackleton N, Luo W, Lam S, Tang-Liu DD-S: Comparison of concentration-time profiles of levobunolol and timolol in anterior and posterior ocular tissues albino rabbits. J Ocular Pharmacol Therap 11: 489-502, 1995.
55. Hof RP: Calcium antagonist and the peripheral circulation: Differences and similarities between PY108-068, nicardipine, verapamil and diltiazem. Br J Pharmac 78: 375-394, 1983.
56. Ohtsuka M, Ono T, Shibayama F: Nilvadipine. Cardiovascular Drug Reviews 6: 97-115, 1988.